PPARα Ligand-Binding Domain Structures with Endogenous Fatty Acids and Fibrates

被引:61
作者
Kamata, Shotaro [1 ]
Oyama, Takuji [2 ]
Saito, Kenta [1 ]
Honda, Akihiro [1 ]
Yamamoto, Yume [1 ]
Suda, Keisuke [1 ]
Ishikawa, Ryo [1 ]
Itoh, Toshimasa [3 ]
Watanabe, Yasuo [4 ]
Shibata, Takahiro [5 ]
Uchida, Koji [6 ]
Suematsu, Makoto [7 ]
Ishii, Isao [1 ]
机构
[1] Showa Pharmaceut Univ, Lab Hlth Chem, Machida, Tokyo 1948543, Japan
[2] Univ Yamanashi, Fac Life & Environm Sci, Kofu, Yamanashi 4008510, Japan
[3] Showa Pharmaceut Univ, Lab Drug Design & Med Chem, Machida, Tokyo 1948543, Japan
[4] Showa Pharmaceut Univ, Lab Pharmacol, Machida, Tokyo 1948543, Japan
[5] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan
[6] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan
[7] Keio Univ, Dept Biochem, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan
基金
日本科学技术振兴机构;
关键词
PROLIFERATOR-ACTIVATED RECEPTORS; CRYSTALLIZATION; RECOGNITION; SELECTIVITY;
D O I
10.1016/j.isci.2020.101727
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Most triacylglycerol-lowering fibrates have been developed in the 1960s-1980s before their molecular target, peroxisome proliferator-activated receptor alpha (PPAR alpha), was identified. Twenty-one ligand-bound PPAR alpha structures have been deposited in the Protein Data Bank since 2001; however, binding modes of fibrates and physiological ligands remain unknown. Here we showthirty-four X-ray crystallographic structures of the PPAR alpha ligand-binding domain, which are composed of a "Center'' and four "Arm'' regions, in complexes with five endogenous fatty acids, sixfibrates in clinical use, and six synthetic PPAR alpha agonists. High-resolution structural analyses, in combination with coactivator recruitment and thermostability assays, demonstrate that stearic and palmitic acids are presumably physiological ligands; coordination to ArmIII is important for high PPAR alpha potency/selectivity of pemafibrate and GW7647; and agonistic activities of four fibrates are enhanced by the partial agonist GW9662. These results renew our understanding of PPAR alpha ligand recognition andcontribute to the molecular design of next-generation PPAR-targeted drugs.
引用
收藏
页数:28
相关论文
共 42 条
[1]   PHENIX: a comprehensive Python']Python-based system for macromolecular structure solution [J].
Adams, Paul D. ;
Afonine, Pavel V. ;
Bunkoczi, Gabor ;
Chen, Vincent B. ;
Davis, Ian W. ;
Echols, Nathaniel ;
Headd, Jeffrey J. ;
Hung, Li-Wei ;
Kapral, Gary J. ;
Grosse-Kunstleve, Ralf W. ;
McCoy, Airlie J. ;
Moriarty, Nigel W. ;
Oeffner, Robert ;
Read, Randy J. ;
Richardson, David C. ;
Richardson, Jane S. ;
Terwilliger, Thomas C. ;
Zwart, Peter H. .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 :213-221
[2]   Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study [J].
Andersson, Charlotte ;
Lyass, Asya ;
Vasan, Ramachandran S. ;
Massaro, Joseph M. ;
D'Agostino, Ralph B. ;
Robins, Sander J. .
AMERICAN HEART JOURNAL, 2014, 168 (06) :878-+
[3]   Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent [J].
Artis, Dean R. ;
Lin, Jack J. ;
Zhang, Chao ;
Wang, Weiru ;
Mehra, Upasana ;
Perreault, Mylene ;
Erbe, David ;
Krupka, Heike I. ;
England, Bruce P. ;
Arnold, James ;
Plotnikov, Alexander N. ;
Marimuthu, Adhirai ;
Nguyen, Hoa ;
Will, Sarah ;
Signaevsky, Maxime ;
Kral, John ;
Cantwell, John ;
Settachatgull, Calvin ;
Yan, Douglas S. ;
Fong, Daniel ;
Oh, Angela ;
Shi, Shenghua ;
Womack, Patrick ;
Powell, Benjamin ;
Habets, Gaston ;
West, Brian L. ;
Zhang, Kam Y. J. ;
Milburn, Michael V. ;
Vlasuk, George P. ;
Hirth, K. Peter ;
Nolop, Keith ;
Bollag, Gideon ;
Ibrahim, Prabha N. ;
Tobin, James F. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (01) :262-267
[4]   Aleglitazar, a new, potent, and balanced dual PPARα/γ agonist for the treatment of type II diabetes [J].
Benardeau, Agnes ;
Benz, Joerg ;
Binggeli, Alfred ;
Blum, Denise ;
Boehringer, Markus ;
Grether, Uwe ;
Hilpert, Hans ;
Kuhn, Bernd ;
Maerki, Hans Peter ;
Meyer, Markus ;
Puentener, Kurt ;
Raab, Susanne ;
Ruf, Armin ;
Schlatter, Daniel ;
Mohr, Peter .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (09) :2468-2473
[5]   Crystallization of soluble proteins in vapor diffusion for x-ray crystallography [J].
Benvenuti, Manuela ;
Mangani, Stefano .
NATURE PROTOCOLS, 2007, 2 (07) :1633-1651
[6]   Molecular Mechanism of Peroxisome Proliferator-Activated Receptor α Activation by WY14643: a New Mode of Ligand Recognition and Receptor Stabilization [J].
Bernardes, Amanda ;
Souza, Paulo C. T. ;
Muniz, Joao R. C. ;
Ricci, Clarisse G. ;
Ayers, Stephen D. ;
Parekh, Nili M. ;
Godoy, Andre S. ;
Trivella, Daniela B. B. ;
Reinach, Peter ;
Webb, Paul ;
Skaf, Munir S. ;
Polikarpov, Igor .
JOURNAL OF MOLECULAR BIOLOGY, 2013, 425 (16) :2878-2893
[7]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[8]   LC/ESI-MS/MS detection of FAs by charge reversal derivatization with more than four orders of magnitude improvement in sensitivity [J].
Bollinger, James G. ;
Rohan, Gajendra ;
Sadilek, Martin ;
Gelb, Michael H. .
JOURNAL OF LIPID RESEARCH, 2013, 54 (12) :3523-3530
[9]   Molecular Actions of PPARα in Lipid Metabolism and Inflammation [J].
Bougarne, Nadia ;
Weyers, Basiel ;
Desmet, Sofie J. ;
Deckers, Julie ;
Ray, David W. ;
Staels, Bart ;
De Bosscher, Karolien .
ENDOCRINE REVIEWS, 2018, 39 (05) :760-802
[10]   Partial agonists activate PPARγ using a helix 12 independent mechanism [J].
Bruning, John B. ;
Chalmers, Michael J. ;
Prasad, Swati ;
Busby, Scott A. ;
Karnenecka, Theodore M. ;
He, Yuanjun ;
Nettles, Kendall W. ;
Griffin, Patrick R. .
STRUCTURE, 2007, 15 (10) :1258-1271